Plasmid DNA for Therapeutic Applications in Cancer

• Egile Nagusiak: David Hernán Martínez-Puente (Egilea), José Juan Pérez-Trujillo (Egilea), Laura Mireya Zavala-Flores (Egilea), Aracely García-García (Egilea), Arnulfo Villanueva-Olivo (Egilea), Humberto Rodríguez-Rocha (Egilea), Jesús Valdés (Egilea), Odila Saucedo-Cárdenas (Egilea), Roberto Montes de Oca-Luna (Egilea), María de Jesús Loera-Arias (Egilea)
• Formatua: Liburua
• Argitaratua: MDPI AG, 2022-09-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Recently, the interest in using nucleic acids for therapeutic applications has been increasing. DNA molecules can be manipulated to express a gene of interest for gene therapy applications or vaccine development. Plasmid DNA can be developed to treat different diseases, such as infections and cancer...